| Monitoring | Variables | Results | N | % |
| 6 Months | Cytopathology | Negative | 45 | 73.8 |
| ASC-US | 13 | 21.3 | ||
| LSIL | 3 | 4.9 | ||
| Complications | Pain | 12 | 19.7 | |
| Purulent Flow | 8 | 13.1 | ||
| 12 Months | Cytopathology | Negative | 43 | 70.5 |
| ASC-US | 13 | 21.3 | ||
| LSIL | 3 | 4.9 | ||
| HSIL | 2 | 3.3 | ||
| Colposcopy | Negative | 56 | 91.8 | |
| Positive | 5 | 8.2 | ||
| Biopsy | Not Performed | 54 | 88.5 | |
| Negative | 2 | 3.3 | ||
| CIN 1 | 3 | 4.9 | ||
| CIN 2/3 | 2 | 3.3 | ||
| General Status | No Injury | 56 | 91.8 | |
| Residual Injury | 5 | 8.2 | ||
| Long-term complications | Absence | 52 | 85.2 | |
| Pain | 6 | 9.8 | ||
| Pelvic Inflammatory Disease | 3 | 5.0 | ||
| 24 Months [8] | Cytopathology | Negative | 55 | 93.2 |
| ASC-US | 2 | 3.4 | ||
| CIN 1 | 1 | 1.7 | ||
| CIN 2/3 | 1 | 1.7 | ||
| Biopsy | Absence of Injury | 2 | 3.4 | |
| CIN 1 | 1 | 1.7 | ||
| CIN 2/3 | 1 | 1.7 | ||
| Not Performed | 55 | 93.2 |